SCR-LIP-000281 · Claim · machine-readable JSON →
In a cross-sectional online survey, lipedema patients more frequently reported hypermobility (44% in adulthood, ~60% in childhood), joint pain, and multisystem symptoms than lymphedema patients, and the authors note lipedema remains underdiagnosed and should be reconceptualized as a systemic connective tissue disorder.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study — Fiengo & Sbarbati (2025) ✓ verified — contextual · cross sectional · 2025 · reading confidence: moderate
“Despite its considerable impact on patients' quality of life, it remains underdiagnosed.”
The article explicitly states lipedema remains underdiagnosed, providing context relevant to the question, but its primary aim concerns pathophysiological overlap with HSD rather than evaluating a screening tool; the instrument was a non-va
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? contextual
- Does lipedema increase the prevalence of joint hypermobility? consistent
- Is lipedema underdiagnosed, misdiagnosed, or diagnosed late? contextual
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-06-02 — merged · absorbed duplicate SCR-LIP-000017
- 2026-05-31 — created · auto-ingested for SQ-LIP-000004